Introducing the open innovation model in Polish biopharmaceutical companies: major drivers and barriers
Innovation is one of the most critical determinants of economic success and one of the most important elements in building a competitive advantage. The COVID-19 pandemic has led to the development of new strategic partnerships, including open innovation alliances, in the biopharmaceutical industry....
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Polish Economic Society
2023-03-01
|
| Series: | Ekonomista |
| Subjects: | |
| Online Access: | https://ekonomista.pte.pl/Introducing-the-open-innovation-model-in-Polish-biopharmaceutical-companies-major,161834,0,2.html |
| Summary: | Innovation is one of the most critical determinants of economic success and one of the most important elements in building a competitive advantage. The COVID-19 pandemic has led to the development of new strategic partnerships, including open innovation alliances, in the biopharmaceutical industry. The adoption of open innovation strategies has been a persistent trend, although these strategies vary onsiderably from one country to another. The lowest level of open cooperation and R&D collaboration in the biopharmaceutical industry can be observed in Central and Eastern Europe, including Poland. The main barriers to, and challenges facing, open innovation cooperation in the Polish biopharma�ceutical sector, however, are not well understood. This study analyses the major drivers of, and barriers to, engaging in open innovation cooperation. A survey was conducted and established that open innovation cooperation and R&D collaboration do not necessarily suffer from a lack of financial resources, but are definitely dependent on such socio-beha�vioural factors as motivation for collaboration, value systems, and trust between partners. |
|---|---|
| ISSN: | 0013-3205 2299-6184 |